leuprolide acetate 30 MG in 0.5 ML (4 month) Prefilled Syringe

RxCUI: 752889
RxNorm name: leuprolide acetate 30 MG in 0.5 ML (4 month) Prefilled Syringe
Display name: leuprolide acetate 30 MG in 0.5 ML (4 month) Prefilled Syringe
Full name: leuprolide acetate 30 MG in 0.5 ML (4 month) Prefilled Syringe
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:17

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Vabrinty	LEUPROLIDE ACETATE	URONOVA PHARMACEUTICALS, INC.	008776cc-83f1-4f8c-819b-6471425da15f	2026-04-30	Warnings, Adverse reactions	Exact identifier rxcui: 752889
Eligard	LEUPROLIDE ACETATE	TOLMAR Inc.	b7b679a9-6823-4ef8-8d31-3ab5058ffcfc	2026-04-30	Warnings, Adverse reactions	Exact identifier rxcui: 752889
ELIGARD	LEUPROLIDE ACETATE	TOLMAR Inc.	b78d1919-9dee-44fa-90f9-e0a26d32481d	2019-04-29	Warnings, Adverse reactions	Exact identifier rxcui: 752889

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
b78d1919-9dee-44fa-90f9-e0a26d32481d	leuprolide acetate 30 MG per 0.5 ML (4 month) Prefilled Syringe	SY	51	These highlights do not include all the information needed to use ELIGARD ® safely and effectively. See full prescribing information for ELIGARD ® . ELIGARD ® (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 2002	20190429
b78d1919-9dee-44fa-90f9-e0a26d32481d	0.5 ML leuprolide acetate 60 MG/ML Prefilled Syringe	SCD	51	These highlights do not include all the information needed to use ELIGARD ® safely and effectively. See full prescribing information for ELIGARD ® . ELIGARD ® (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 2002	20190429
b78d1919-9dee-44fa-90f9-e0a26d32481d	leuprolide acetate 30 MG in 0.5 ML (4 month) Prefilled Syringe	PSN	51	These highlights do not include all the information needed to use ELIGARD ® safely and effectively. See full prescribing information for ELIGARD ® . ELIGARD ® (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 2002	20190429
b7b679a9-6823-4ef8-8d31-3ab5058ffcfc	0.5 ML leuprolide acetate 60 MG/ML Prefilled Syringe	SCD	19	These highlights do not include all the information needed to use ELIGARD ® safely and effectively. See full prescribing information for ELIGARD. ELIGARD (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 2002	20260430
b7b679a9-6823-4ef8-8d31-3ab5058ffcfc	leuprolide acetate 30 MG in 0.5 ML (4 month) Prefilled Syringe	PSN	19	These highlights do not include all the information needed to use ELIGARD ® safely and effectively. See full prescribing information for ELIGARD. ELIGARD (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 2002	20260430
b7b679a9-6823-4ef8-8d31-3ab5058ffcfc	leuprolide acetate 30 MG per 0.5 ML (4 month) Prefilled Syringe	SY	19	These highlights do not include all the information needed to use ELIGARD ® safely and effectively. See full prescribing information for ELIGARD. ELIGARD (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 2002	20260430
008776cc-83f1-4f8c-819b-6471425da15f	leuprolide acetate 30 MG per 0.5 ML (4 month) Prefilled Syringe	SY	9	These highlights do not include all the information needed to use VABRINTY™ safely and effectively. See full prescribing information for VABRINTY. VABRINTY (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 2002	20250601
008776cc-83f1-4f8c-819b-6471425da15f	0.5 ML leuprolide acetate 60 MG/ML Prefilled Syringe	SCD	9	These highlights do not include all the information needed to use VABRINTY™ safely and effectively. See full prescribing information for VABRINTY. VABRINTY (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 2002	20250601
008776cc-83f1-4f8c-819b-6471425da15f	leuprolide acetate 30 MG in 0.5 ML (4 month) Prefilled Syringe	PSN	9	These highlights do not include all the information needed to use VABRINTY™ safely and effectively. See full prescribing information for VABRINTY. VABRINTY (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 2002	20250601